Oct 15, 1977

Viruses and the pathogenesis of human leukemia

Schweizerische medizinische Wochenschrift
R C Gallo


The first part of this review deals with some new ideas on the nature of acute myelogenous leukemic cells. It is shown that the bloc in the differentiation process which characterizes these malignant cells can, to a certain extent, be overcome by some differentiation promoting proteins which are described. The finding that leukemic cells may respond to these "factors" indicates that these cells are not completely autonomous. Further studies in this field will clarify some biochemical and virological questions related to malignant transformation. In the second part, information on RNA tumor viruses is presented and their role in animal leukemias and possible involvement in humans are discussed. Whereas there is firm evidence for the presence of oncornavirus-related information in the human population, no cohesive pattern has emerged allowing definitive etiological inferences.

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Pathogenic Aspects
Antibodies, Viral
RNA Viruses
Virus Replication
Hairy Cell Leukemia
RNA Virus Infections
Leukemia, Monocytic, Chronic
Lymphocyte Activation

About this Paper

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.